Recruitment

Recruitment Status
Enrolling by invitation
Estimated Enrollment
95

Summary

Conditions
  • Arrhythmias Cardiac
  • Autonomic Nervous System Diseases
  • Cardiovascular Diseases
  • Orthostatic Intolerance
  • Postural Orthostatic Tachycardia Syndrome
  • Postural Tachycardia Syndrome
  • Primary Dysautonomias
  • Tachycardia
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 50 years
Gender
Both males and females

Description

Postural tachycardia syndrome (POTS) is a debilitating disorder resulting from cardiovascular autonomic dysfunction, has many causes and is very difficult to treat effectively. The investigators have identified the presence of autoantibodies (immune proteins) directed against some receptors of the a...

Postural tachycardia syndrome (POTS) is a debilitating disorder resulting from cardiovascular autonomic dysfunction, has many causes and is very difficult to treat effectively. The investigators have identified the presence of autoantibodies (immune proteins) directed against some receptors of the autonomic nervous system that can cause patient's symptoms on standing. The present study is designed to test the hypothesis that patients with POTS harbor functional autoantibodies to adrenergic receptors that lead to an excessive tachycardia characteristic of POTS. For this purpose, this study will define the prevalence, burden, and the in vivo physiological significance of these adrenergic antibodies in a well-phenotyped and representative cohort of patients with POTS and a matched cohort of healthy control subjects, and will characterize the stability of these autoantibodies over time in affected POTS patients.

Tracking Information

NCT #
NCT02725060
Collaborators
University of Oklahoma
Investigators
Principal Investigator: Luis Okamoto, MD Vanderbilt University Medical Center